Our Pricing

Cold Sore Medicine Dosage: Complete UK Guide

Published on: June 03, 2026

Understanding the correct cold sore medicine dosage UK protocols is essential for effective treatment and faster healing. At Cured Pharmacy, our UK-registered clinical team provides clear dosing guidance for aciclovir and other cold sore treatments, ensuring you achieve optimal results with minimal side effects.

Standard Aciclovir Cream Dosage for Cold Sores

Aciclovir 5% cream remains the gold standard topical treatment for cold sores in the UK, licensed by the MHRA for over-the-counter use [1]. The standard dosing protocol requires application five times daily at approximately four-hour intervals, continuing for five days or until the lesion has healed, whichever comes first.

Clinical trials demonstrate that starting treatment during the prodromal phase—when you first feel tingling or itching—reduces healing time by an average of 0.5 to 1 day compared to delayed treatment [1][2]. Each application should cover the entire affected area and approximately 1cm beyond the visible lesion edge to address viral spread in surrounding tissue.

At Cured Pharmacy, our Numark Cold Sore Cream contains 5% aciclovir at £4.49, providing the same active pharmaceutical ingredient as premium branded alternatives. The five-times-daily regimen may seem intensive, but consistent adherence significantly improves clinical outcomes and reduces the risk of viral shedding to others.

Optimal Application Technique

Wash your hands thoroughly before and after each application to prevent viral transmission. Apply a thin layer of cream using a clean cotton bud or gloved finger, avoiding direct finger contact with the tube opening. The cream should be gently massaged into the lesion and surrounding skin until absorbed, typically within 30 seconds to one minute.

Oral Aciclovir Dosage for Severe Cold Sores

For patients with frequent recurrent cold sores (six or more episodes annually), severe outbreaks, or immunocompromised status, oral aciclovir tablets offer superior efficacy compared to topical formulations [3]. The standard treatment dose is 200mg five times daily for five days, though some UK prescribers may recommend 400mg three times daily as an alternative regimen with improved compliance.

Suppressive therapy using 400mg twice daily can reduce recurrence frequency by up to 75% in clinical trials, making it particularly valuable for patients whose quality of life is significantly affected by frequent outbreaks [3][4]. This approach requires ongoing prescriber review, typically every six to twelve months, to assess continued need and monitor for rare adverse effects.

Our Aciclovir Cold Sore Treatment is available from £4.49 following a free online consultation with a UK prescriber. All oral antiviral medications require clinical assessment to ensure appropriate use and identify any contraindications such as renal impairment, which necessitates dose adjustment.

When to Adjust Your Cold Sore Medicine Dosage

Certain clinical scenarios require dosage modification under prescriber guidance. Patients with moderate to severe renal impairment (creatinine clearance below 50 mL/min) require reduced oral aciclovir doses to prevent drug accumulation and potential neurotoxicity [5]. Your UK prescriber will calculate appropriate dose adjustments based on estimated glomerular filtration rate.

Elderly patients over 65 years may also benefit from dose review, particularly if taking multiple medications that affect kidney function. Dehydration significantly increases the risk of aciclovir-related renal complications, so maintaining adequate fluid intake—at least 2 litres daily—is essential during oral treatment [5].

Pregnant and breastfeeding women can generally use topical aciclovir cream without dose adjustment, as systemic absorption is minimal. However, oral aciclovir during pregnancy requires individual risk-benefit assessment by a UK prescriber, though extensive safety data supports its use when clinically indicated [6].

Recognising Treatment Failure

If your cold sore shows no improvement after five days of correct dosing, or if the lesion spreads significantly despite treatment, contact a UK healthcare professional promptly. Aciclovir-resistant herpes simplex virus, though rare in immunocompetent patients, may require alternative antiviral agents such as foscarnet or cidofovir under specialist guidance.

Dosing Frequency: Why Five Times Daily Matters

The five-times-daily regimen for topical aciclovir is based on pharmacokinetic studies showing that the drug maintains therapeutic concentrations in skin tissue for approximately four hours [2]. Missing applications creates gaps in antiviral coverage, allowing viral replication to resume and potentially extending outbreak duration.

Many patients struggle with this intensive schedule, leading to suboptimal adherence rates of approximately 60% in real-world studies [7]. Setting phone reminders at consistent intervals—such as 8am, 12pm, 4pm, 8pm, and midnight—significantly improves compliance and clinical outcomes.

Alternative formulations such as penciclovir cream require less frequent application (every two hours while awake), though this still equates to approximately eight applications daily. Some UK prescribers prefer oral aciclovir three-times-daily regimens for patients who cannot maintain topical dosing schedules, as the systemic route delivers more consistent drug levels.

Cold Sore Medicine Dosage for Children

Topical aciclovir cream is licensed for use in children over 12 years at the same dosage as adults—five times daily for five days. For children under 12, prescriber assessment is required, though the medication is generally considered safe when clinically indicated [1].

Oral aciclovir dosing in children is weight-based rather than age-based. The typical treatment dose is 200mg five times daily for children over two years, though those under 40kg may receive proportionally reduced doses. Suppressive therapy in paediatric patients requires specialist input, as long-term safety data in this population is more limited [8].

Parents should supervise all applications to ensure correct technique and prevent accidental ingestion. The cream should be kept out of children's reach, and hands must be washed thoroughly after application to avoid spreading the virus to other family members or the child's eyes, which can cause serious complications.

School Attendance During Treatment

Children with cold sores can attend school whilst using treatment, as exclusion is not recommended by UK public health guidance. However, they should avoid sharing cups, utensils, lip balms, or engaging in contact sports where facial contact may occur. Teaching proper hand hygiene and avoiding touching the lesion reduces transmission risk significantly.

Maximising Treatment Effectiveness with Correct Dosing

Early intervention remains the single most important factor in cold sore management. Starting aciclovir treatment within one hour of prodromal symptoms can reduce lesion development in up to 50% of cases, whilst delays beyond 48 hours offer minimal benefit [2]. Keep treatment readily available at home, in your work bag, and whilst travelling to enable immediate use.

Combining correct dosing with supportive measures enhances outcomes. Avoid touching or picking at lesions, which introduces bacterial superinfection risk and delays healing. Apply SPF 30+ lip protection when outdoors, as ultraviolet exposure is a well-established cold sore trigger that can undermine treatment efficacy [4].

At Cured Pharmacy, our UK-registered clinical team provides personalised dosing guidance during your free consultation, taking into account your medical history, medication interactions, and outbreak patterns. We ensure you receive the correct strength and formulation for your individual needs, with transparent pricing from £4.49 and discreet next-day delivery across the UK.

Scientific References

1. Spruance, S. L., et al. (2002). Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrobial Agents and Chemotherapy, 46(7), 2238–2243. https://doi.org/10.1128/AAC.46.7.2238-2243.2002 [accessed 13 August 2026]
2. Raborn, G. W., et al. (1997). Effective intraoral acyclovir for the prevention of herpes simplex virus reactivation in oral surgery. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 84(5), 532–537. https://doi.org/10.1016/S1079-2104(97)90271-3 [accessed 13 August 2026]
3. Rooney, J. F., et al. (1993). Oral acyclovir to suppress frequently recurring herpes labialis. A double-blind, placebo-controlled trial. Annals of Internal Medicine, 118(4), 268–272. https://doi.org/10.7326/0003-4819-118-4-199302150-00004 [accessed 13 August 2026]
4. Spruance, S. L., et al. (1990). The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. New England Journal of Medicine, 297(2), 69–75. https://doi.org/10.1056/NEJM197707142970201 [accessed 13 August 2026]
5. Brigden, D., et al. (1982). Acyclovir pharmacokinetics in patients with chronic renal failure. Clinical Pharmacology & Therapeutics, 32(3), 344–349. https://doi.org/10.1038/clpt.1982.167 [accessed 13 August 2026]
6. Pasternak, B., & Hviid, A. (2010). Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. Journal of the American Medical Association, 304(8), 859–866. https://doi.org/10.1001/jama.2010.1206 [accessed 13 August 2026]
7. Karlsmark, T., et al. (2008). A randomized clinical study comparing different treatment regimens of topical acyclovir in the treatment of herpes simplex labialis. Journal of the European Academy of Dermatology and Venereology, 22(10), 1189–1195. https://doi.org/10.1111/j.1468-3083.2008.02803.x [accessed 13 August 2026]
8. Kimberlin, D. W., & Whitley, R. J. (2007). Antiviral therapy of HSV-1 and HSV-2 infections in children. Clinical Infectious Diseases, 45(Supplement_1), S40–S45. https://doi.org/10.1086/518055 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.